NCT00677300 - Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

October 31, 2012

Study Completion Date

December 31, 2012

Conditions

HIV Infections

Interventions

DRUG

Raltegravir

400mg P.O. (orally) twice daily for 48 weeks

DRUG

Darunavir

800 mg P.O. (orally) once daily

DRUG

Ritonavir

100mg once daily

DRUG

Tenofovir/Emtricitabine

300 mg/200 mg P.O. (orally) once daily

Trial Locations (2)

Dallas VA Medical Center, Dallas

Parkland Health & Hospital System, Dallas